Recently, the studies on the antiviral activities of marine natural products, especially marine polysaccharides, are attracting more and more attention all over the world. Marine-derived polysaccharides and their lower molecular weight oligosaccharide derivatives have been shown to possess a variety of antiviral activities. This paper will review the recent progress in research on the antiviral activities and the mechanisms of these polysaccharides obtained from marine organisms. In particular, it will provide an update on the antiviral actions of the sulfated polysaccharides derived from marine algae including carrageenans, alginates, and fucans, relating to their structure features and the structure–activity relationships. In addition, the recent findings on the different mechanisms of antiviral actions of marine polysaccharides and their potential for therapeutic application will also be summarized in detail.
References
[1]
De Clercq, E. Antiviral drugs in current chemical reviews. J. Clin. Virol. 2004, 30, 115–133, doi:10.1016/j.jcv.2004.02.009.
[2]
Laurienzo, P. Marine polysaccharides in pharmaceutical applications: An overview. Mar. Drugs 2010, 8, 2435–2465, doi:10.3390/md8092435.
[3]
Jiao, G.L.; Yu, G.L.; Wang, W.; Zhao, X.L.; Zhang, J.Z.; Stephen, H.E. Properties of polysaccharides in several seaweeds from Atlantic Canada and their potential anti-influenza viral activities. J. Ocean Univ. China 2012, 11, 205–212, doi:10.1007/s11802-012-1906-x.
[4]
Huang, Y.L.; Zheng, T.L. Studies on polysaccharides from marine organism, a review. Mar. Sci. 2004, 28, 58–61.
[5]
Singh, K.; Ray, A.R. Biomedical applications of chitin, chitosan, and their derivative. J. Macromol. Sci. 2000, 40, 69–83, doi:10.1081/MC-100100579.
[6]
Zierer, M.S.; Mourao, P.S. A wide diversity of sulfated polysaccharides are synthesized by different species of marine sponges. Carbohydr. Res. 2000, 328, 209–216, doi:10.1016/S0008-6215(00)00076-8.
[7]
Ngo, D.N.; Kim, M.M.; Kim, S.K. Chitin oligosaccharides inhibit oxidative stress in live cells. Carbohydr. Polym. 2008, 74, 228–234, doi:10.1016/j.carbpol.2008.02.005.
[8]
Burrows, F.; Louime, C.; Abazinge, M.; Onokpise, O. Extraction and evaluation of chitin from crub exoskeleton as a seed fungicide and plant growth enhancer. Am. Eurasian J. Agric. Environ. Sci. 2007, 2, 103–111.
[9]
Kim, S.K.; Nghiep, N.D.; Rajapakse, N. Therapeutic prospectives of chitin, chitosan and their derivatives. J. Chitin Chitosan 2006, 11, 1–10.
[10]
Jayakumar, R.; New, N.; Nagagama, H.; Furuike, T.; Tamura, H. Synthesis, characterization and biospecific degradation behavior of sulfated chitin. Macromol. Symp. 2008, 264, 163–167, doi:10.1002/masy.200850426.
[11]
Suwan, J.; Zhang, Z.; Li, B.; Vongchan, P.; Meepowpan, P.; Zhang, F.; Mousa, S.A.; Mousa, S.; Premanode, B.; Kongtawelert, P.; et al. Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity. Carbohydr. Res. 2009, 344, 1190–1196, doi:10.1016/j.carres.2009.04.016.
[12]
He, Q.; Ao, Q.; Wang, A.; Gong, Y.; Zhao, N.; Zhang, X. In vitro cytotoxicity and protein drug release properties of chitosan/heparin microspheres. Tsinghua Sci. Technol. 2007, 12, 361–365, doi:10.1016/S1007-0214(07)70054-8.
[13]
Thierry, B.; Merhi, Y.; Silver, J.; Tabrizian, M. Biodegradable membrane-covered stent from chitosan-based polymers. J. Biomed. Mater. Res. 2005, 75, 556–566.
[14]
Prabaharan, M.; Reis, R.L.; Mano, J.F. Carboxymethyl chitosan-graft-phosphatidylethanolamine: Amphiphilic matrices for controlled drug delivery. React. Funct. Polym. 2007, 67, 43–52, doi:10.1016/j.reactfunctpolym.2006.09.001.
[15]
Gonzalez, R.P.; Leyva, A.; Moraes, M.O. Shark cartilage as source of antiangiogenic compounds: From basic to clinical research. Biol. Pharm. Bull. 2001, 24, 1097–1101, doi:10.1248/bpb.24.1097.
[16]
Cimino, P.; Bifulco, G.; Casapullo, A.; Bruno, I.; Gomez-Paloma, L.; Riccio, R. Isolation and NMR characterization of rosacelose, a novel sulfated polysaccharide from the sponge Mixylla rosacea. Carbohydr. Res. 2001, 334, 39–47, doi:10.1016/S0008-6215(01)00141-0.
[17]
Huang, Y.L.; Zheng, Z.H.; Su, W.J.; Chen, F.; Wu, P.R.; Fang, J.R. Studies on the chemical composition of sea cucumber mensamar intercede III. Immunomodulative effects of PMI-1. Mar. Sci. Bull. 2001, 20, 88–91.
[18]
Jiao, G.; Yu, G.; Zhang, J.; Ewart, S.H. Chemical structures and bioactivities of sulphated polysaccharides from marine algae. Mar. Drugs 2011, 9, 196–223, doi:10.3390/md9020196.
[19]
Rioux, L.E.; Turgeon, S.L.; Beaulieu, M. Characterization of polysaccharides extracted from brown seaweeds. Carbohydr. Polym. 2007, 69, 530–537, doi:10.1016/j.carbpol.2007.01.009.
[20]
Mabeau, S.; Kloareg, B. Isolation and analysis of the cell walls of brown algae: Fucus spiralis, F. ceranoides, F. vesiculosus, F. serratus, Bifurcaria bifurcata and Laminaria digitata. J. Exp. Bot. 1986, 38, 1573–1580, doi:10.1093/jxb/38.9.1573.
[21]
Lu, F.; Wei, X.; Zhao, R. Fucoidans: Structure and bioactivity. Molecules 2008, 13, 1671–1695, doi:10.3390/molecules13081671.
[22]
Knutsen, S.H.; Myslabodski, D.E.; Larsen, B.; Usov, A.I. A modified system of nomenclature for red algal galactans. Bot. Mar. 1994, 37, 163–170.
[23]
Liu, X.; Xu, F.; Shao, C.; She, Z.; Lin, Y.; Chan, W.L. Bioactive Metabolites from Marine Microorganisms. In Studies in Natural Products Chemistry; Atta-ur-Rahman, F.R.S., Ed.; Elsevier Science Publishers: Amsterdam, The Netherlands, 2008; pp. 197–310.
[24]
Debbab, A.; Aly, A.H.; Lin, W.H.; Proksch, P. Bioactive compounds from marine bacteria and fungi. Microb. Biotechnol. 2010, 3, 544–563, doi:10.1111/j.1751-7915.2010.00179.x.
[25]
Waters, A.L.; Hill, R.T.; Place, A.R.; Hamann, M.T. The expanding role of marine microbes in pharmaceutical development. Curr. Opin. Biotechnol. 2010, 21, 780–786, doi:10.1016/j.copbio.2010.09.013.
[26]
Thomas, T.R.A.; Kaulekar, D.P.; Lokabarathi, P.A. Marine drugs from sponge microbe association: A review. Mar. Drugs 2010, 8, 1417–1468, doi:10.3390/md8041417.
[27]
Zheng, T.L.; Hong, H.S.; Wang, F.; Maskaoui, K.; Su, J.; Tian, Y. The distribution characters of bacteria β-glucosidase activity in the Taiwan Strait. Mar. Pollut. Bull. 2002, 45, 168–176, doi:10.1016/S0025-326X(02)00162-5.
[28]
Lee, J.B.; Hayashi, T.; Hayashi, K.; Sankawa, U. Structural analysis of calcium spirulan (Ca-SP)-derived oligosaccharides using electrospray ionization mass spectrometry. J. Nat. Prod. 2000, 63, 136–138, doi:10.1021/np990348b.
[29]
Roger, O.; Kervarec, N.; Ratiskol, J.; Colliec-Jouault, S.; Chevolot, L. Structural studies of the main exopolysaccharide produced by the deep-sea bacterium Alteromonas infernus. Carbohydr. Res. 2004, 339, 2371–2380, doi:10.1016/j.carres.2004.07.021.
[30]
McCandless, E.L.; Craigie, J.S. Sulphated polysaccharides in red and brown algae. Planta 1979, 112, 201–212, doi:10.1007/BF00385324.
[31]
Lahaye, M. Developments on gelling algal galactans, their structure and physico-chemistry. J. Appl. Phycol. 2001, 13, 173–184, doi:10.1023/A:1011142124213.
[32]
Chiu, Y.H.; Chan, Y.L.; Tsai, L.W.; Li, T.L.; Wu, C.J. Prevention of human enterovirus 71 infection by kappa carrageenan. Antivir. Res. 2012, 95, 128–134, doi:10.1016/j.antiviral.2012.05.009.
[33]
Talarico, L.B.; Damonte, E.B. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 2007, 363, 473–485, doi:10.1016/j.virol.2007.01.043.
[34]
Grassauer, A.; Weinmuellner, R.; Meier, C.; Pretsch, A.; Prieschl-Grassauer, E.; Unger, H. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol. J. 2008, 5, 107, doi:10.1186/1743-422X-5-107.
[35]
Carlucci, M.J.; Scolaro, L.A.; Noseda, M.D.; Cerezo, A.S.; Damonte, E.B. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antivir. Res. 2004, 64, 137–141.
[36]
Leibbrandt, A.; Meier, C.; K？nig-Schuster, M.; Weinmüllner, R.; Kalthoff, D.; Pflugfelder, B.; Graf, P.; Frank-Gehrke, B.; Beer, M.; Fazekas, T.; et al. Iota-carrageenan is a potent inhibitor of influenza A virus infection. PLoS One 2010, 5, e14320.
[37]
Talarico, L.B.; Noseda, M.D.; Ducatti, D.R.B.; Duarte, M.E.; Damonte, E.B. Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan. J. Gen. Virol. 2011, 92, 1332–1342, doi:10.1099/vir.0.028522-0.
[38]
Buck, C.B.; Thompson, C.D.; Roberts, J.N.; Muller, M.; Lowy, D.R.; Schiller, J.T. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006, 2, e69, doi:10.1371/journal.ppat.0020069.
[39]
Yamada, T.; Ogamo, A.; Saito, T.; Uchiyama, H.; Nakagawa, Y. Preparation of O-acylated low-molecular-weight carrageenans with potent anti-HIV activity and low anticoagulant effect. Carbohydr. Polym. 2000, 41, 115–120, doi:10.1016/S0144-8617(99)00083-1.
[40]
Yamada, T.; Ogamo, A.; Saito, T.; Watanabe, J.; Uchiyama, H.; Nakagawa, Y. Preparation and anti-HIV activity of low-molecular-weight carrageenans and their sulfated derivatives. Carbohydr. Polym. 1997, 32, 51–55, doi:10.1016/S0144-8617(96)00128-2.
[41]
Ji, J.; Wang, L.C.; Wu, H.; Luan, H.M. Bio-function summary of marine oligosaccharides. Int. J. Biol. Sci. 2011, 3, 74–86.
[42]
Tang, F.; Chen, F.; Li, F. Preparation and potential in vivo anti-influenza virus activity of low molecular-weight κ-carrageenans and their derivatives. J. Appl. Polym. Sci. 2012, doi:10.1002/app.37502.
[43]
Wang, W.; Zhang, P.; Hao, C.; Zhang, X.E.; Cui, Z.Q.; Guan, H.S. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antivir. Res. 2011, 92, 237–246, doi:10.1016/j.antiviral.2011.08.010.
[44]
Wang, W.; Zhang, P.; Yu, G.L.; Li, C.X.; Hao, C.; Qi, X.; Zhang, L.J.; Guan, H.S. Preparation and anti-influenza A virus activity of κ-carrageenan oligosaccharide and its sulphated derivatives. Food Chem. 2012, 133, 880–888, doi:10.1016/j.foodchem.2012.01.108.
Carlucci, M.J.; Ciancia, M.; Matulewicz, M.C.; Cerezo, A.S.; Damonte, E.B. Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antivir. Res. 1999, 43, 93–102.
[47]
Girond, S.; Crance, J.M.; van Cuyck-Gandre, H.; Renaudet, J.; Deloince, R. Antiviral activity of carrageenan on hepatitis A virus replication in cell culture. Res. Virol. 1991, 142, 261–270, doi:10.1016/0923-2516(91)90011-Q.
[48]
Talarico, L.B.; Pujol, C.A.; Zibetti, R.G.; Faría, P.C.; Noseda, M.D.; Duarte, M.E.; Damonte, E.B. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antivir. Res. 2005, 66, 103–110.
Douglas, M.S.; Ali, S.; Rix, D.A.; Zhang, J.G.; Kirby, J.A. Endothelial production of MCP-1: Modulation by heparin and consequences for mononuclear cell activation. Immunology 1997, 92, 512–518.
[51]
Yu, L.; Garg, H.G.; Li, B.; Linhardt, R.J.; Hales, C.A. Antitumor effect of butanoylated heparin with low anticoagulant activity on lung cancer growth in mice and rats. Curr. Cancer Drug Targets 2010, 10, 229–241, doi:10.2174/156800910791054176.
[52]
Copeland, R.; Balasubramaniam, A.; Tiwari, V.; Zhang, F.; Bridges, A.; Linhardt, R.J.; Shukla, D.; Liu, J. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 2008, 47, 5774–5783.
[53]
Ramos-Kuri, M.; Barron Romero, B.L.; Aguilar-Setien, A. Inhibition of three alpha herpes viruses (herpes simplex 1 and 2 and pseudo rabies virus) by heparin, heparan and other sulfated polyelectrolytes. Arch. Med. Res. 1996, 27, 43–48.
[54]
Neyts, J.; Snoeck, R.; Schols, D.; Balzarini, J.; Esko, J.D.; van Schepdael, A.; de Clercq, E. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 1992, 189, 48–58, doi:10.1016/0042-6822(92)90680-N.
[55]
Okazaki, K.; Matsuzaki, T.; Sugahara, Y.; Okada, J.; Hasebe, M.; Iwamura, Y.; Ohnishi, M.; Kanno, T.; Shimizu, M.; Honda, E. BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology 1991, 181, 666–670, doi:10.1016/0042-6822(91)90900-V.
[56]
Kari, B.; Gehrz, R. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 1992, 66, 1761–1764.
[57]
Madeleine, L.M.; Reinhard, G. Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo. Antivir. Res. 1990, 14, 39–50, doi:10.1016/0166-3542(90)90064-E.
[58]
Witvrouw, M.; Schols, D.; Andrei, G.; Snoeck, R.; Hosoya, M.; Pauwels, R.; Balzarini, J.; de Clercq, E. Antiviral activity of low-MW dextran sulphate (derived from dextran MW 1000) compared to dextran sulphate samples of higher MW. Antivir. Chem. Chemother. 1991, 2, 171–179.
[59]
Ivanova, V.; Rouseva, R.; Kolarova, M.; Serkedjieva, J.; Rachev, R.; Manolova, N. Isolation of a polysaccharide with antiviral effect from Ulva lactuca. Prep. Biochem. 1994, 24, 83–97, doi:10.1080/10826069408010084.
[60]
Vo, T.-S.; Kim, S.-K. Potential anti-HIV agents from marine resources: An overview. Mar. Drugs 2010, 8, 2871–2892, doi:10.3390/md8122871.
[61]
Xin, X.L.; Geng, M.Y.; Guan, H.S.; Li, Z.L. Study on the mechanism of inhibitory action of 911 on replication of HIV-1 in vitro. Chin. J.Mar. Drugs 2000, 19, 15–18.
[62]
Xin, X.L.; Ding, H.; Geng, M.Y.; Liang, P.F.; Li, Y.X.; Guan, H.S. Studies of the anti-AIDS effects of marine polysaccharide drug 911 and its related mechanisms of action. Chin. J. Mar. Drugs 2000, 6, 4–8.
[63]
Geng, M.Y.; Li, F.C.; Xin, X.L.; Li, J.; Yan, Z.W.; Guan, H.S. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry Interaction between SPMG and HIV-1 gp120 and CD4 molecule. Antivir. Res. 2003, 59, 127–135.
[64]
Miao, B.C.; Geng, M.Y.; Li, J.; Li, F.; Chen, H.; Guan, H.S.; Ding, J. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocyte. Biochem. Pharmacol. 2004, 68, 641–649, doi:10.1016/j.bcp.2004.04.009.
[65]
Liu, H.Y.; Geng, M.Y.; Xin, X.L.; Li, F.C.; Chen, H.X.; Guan, H.S.; Ding, J. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activitie. Glycobiology 2005, 15, 501–510.
[66]
Jiang, B.F.; Xu, X.F.; Li, L.; Yuan, W. Study on “911” anti-HBV effect in HepG2.2.15 cells culture. Mod. Prev. Med. 2003, 30, 517–518.
[67]
Queiroz, K.C.S.; Medeiros, V.P.; Queiroz, L.S.; Abreu, L.R.D.; Rocha, H.A.O.; Ferreira, C.V.; Juca, M.B.; Aoyama, H.; Leite, E.L. Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae. Biomed. Pharmacother. 2008, 62, 303–307, doi:10.1016/j.biopha.2008.03.006.
[68]
Hidari, K.I.P.J.; Takahashi, N.; Arihara, M.; Nagaoka, M.; Morita, K.; Suzuki, T. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem. Biophys. Res. Commun. 2008, 376, 91–95, doi:10.1016/j.bbrc.2008.08.100.
[69]
Akamatsu, E.; Shimanaga, M.; Kamei, Y. Isolation of an anti-influenza virus substance, MC26 from a marine brown alga Sargassum piluliferum and its antiviral activity against influenza virus. Coast. Bioenviron. 2003, 1, 29–34.
[70]
Muto, S.; Niimura, K.; Oohara, M.; Oguchi, Y.; Matsunaga, K.; Hirose, K.; Kakuchi, J.; Sugita, N.; Furusho, T. Polysaccharides from marine algae and antiviral drugs containing the same as active ingredients. Eur. Patent EP295956, 21 December 1988.
[71]
Yu, N.; Liu, S.; Han, J.J.; Sun, F.S. The depressive effect of glycosaminoglycan from scallop on type-I herpes simplex virus. Acta Acad. Med. Qingdao Univ. 2008, 2, 111–114.
[72]
Zhang, H.F.; Li, J.B.; Hou, G.; Huang, D.N. Study on the inhibition effects of Perna viridis polysaccharides on influenza virus reproduction in MDCK cell cultures. Mod. Med. J. China 2008, 5, 4–7.
[73]
Wu, S.M.; Xu, W.M.; Xu, Z.; Lin, F.; Sheng, L. Antiviral effect of oyster extract compound capsule in ducks infected by DHBV. Chin. Pharm. J. 1996, 31, 304–307.
[74]
Woo, E.R.; Kim, W.S.; Kim, Y.S. Virus-cell fusion inhibitory activity for the polysaccharides from various Korean edible clams. Arch. Pharm. Res. 2001, 24, 514–517, doi:10.1007/BF02975155.
[75]
Davis, R.; Zivanovic, S.; D’Souza, D.H.; Davidson, M.P. Effectiveness of chitosan on the inactivation of enteric viral surrogates. Food Microbiol. 2012, 32, 57–62, doi:10.1016/j.fm.2012.04.008.
[76]
Pospieszny, H.; Chirkov, S.; Atabekov, J. Induction of antiviral resistance in plants by chitosan. Plant Sci. 1991, 79, 63–68, doi:10.1016/0168-9452(91)90070-O.
Chirkov, S.N. The antiviral activity of chitosan (review). Appl. Biochem. Microbiol. 2002, 38, 1–8, doi:10.1023/A:1013206517442.
[79]
Kulikov, S.N.; Chirkov, S.N.; Il’ina, A.V.; Lopatin, S.A.; Varlamov, V.P. Effect of the molecular weight of chitosan on its antiviral activity in plants. Prik. Biokhim. Mikrobiol. 2006, 42, 224–228.
Nishimura, S.I.; Kai, H.; Shinada, K.; Yoshida, T.; Tokura, S.; Kurita, K.; Nakashima, H.; Yamamoto, N.; Uryu, T. Regioselective syntheses of sulfated polysaccharides: Specific anti-HIV-1 activity of novel chitin sulfates. Carbohydr. Res. 1998, 306, 427–433, doi:10.1016/S0008-6215(97)10081-7.
[82]
Dou, J.L.; Tan, C.Y.; Du, Y.G.; Bai, X.F.; Wang, K.Y.; Ma, X.J. Effects of chitooligosaccharides on rabbit neutrophils in vitro. Carbohydr. Polym. 2007, 69, 209–213, doi:10.1016/j.carbpol.2006.09.029.
[83]
Jeon, Y.J.; Kim, S.K. Continuous production of chitooligosaccharides using a dual reactor system. Process Biochem. 2000, 35, 623–632, doi:10.1016/S0032-9592(99)00118-1.
[84]
Jeon, Y.J.; Kim, S.K. Production of chitooligosaccharides using ultrafiltration membrane reactor and their antibacterial activity. Carbohydr. Polym. 2000, 41, 133–141, doi:10.1016/S0144-8617(99)00084-3.
[85]
Artan, M.; Karadeniz, F.; Karagozlu, M.Z.; Kim, M.M.; Kim, S.K. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr. Res. 2010, 345, 656–662, doi:10.1016/j.carres.2009.12.017.
[86]
Pospieszny, H.; Atabekov, J.G. Effect of chitosan on the hypersensitive reaction of bean to alfalfa mosaic virus. Plant Sci. 1989, 62, 29–31, doi:10.1016/0168-9452(89)90185-4.
[87]
Guan, H.S. New drug—Polymannuronic acid propyl sulfates. China Patent 93100608.2, 6 July 1994.
[88]
Guan, H.S. New drug—polymeric mannuronic acids sulfate. China Patent 95110396.2, 2 October 1996.
[89]
Wang, W.; Yu, G.L.; Hao, C.; Guan, H.S. The application of one kind of oligomeric mannuronic acid in the preparation of anti-influenza A H1N1 virus drugs. China Patent 201110408962.7, 9 December 2011.
[90]
Wang, W.; Li, C.X.; Guan, H.S.; Yu, G.L.; Wang, S.X. The application of polymannuronic acid propyl sulfate in the preparation of drugs against influenza A (H1N1) virus. China Patent 201210201876.3, 18 June 2012.
[91]
Kanekiyo, K.; Hayashi, K.; Takenaka, H.; Lee, J.B.; Hayashi, T. Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme. Biol. Pharm. Bull. 2007, 30, 1573–1575, doi:10.1248/bpb.30.1573.
[92]
Kim, M.; Yim, J.H.; Kim, S.Y.; Kim, H.S.; Lee, W.G.; Kim, S.J.; Kang, P.S.; Lee, C.K. In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03. Antivir. Res. 2012, 93, 253–259, doi:10.1016/j.antiviral.2011.12.006.
[93]
Carlucci, M.J.; Scolaro, L.A.; Damonte, E.B. Herpes simplex virus type 1variants arising after selection with an antiviral carageenan: Lack of correlation between drug susceptibility and synphenotype. J. Med. Virol. 2002, 68, 92–98, doi:10.1002/jmv.10174.
[94]
Harden, E.A.; Falshaw, R.; Carnachan, S.M.; Kern, E.R.; Prichard, M.N. Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antivir. Res. 2009, 83, 282–289, doi:10.1016/j.antiviral.2009.06.007.
[95]
Su, X.W.; Zivanovic, S.; D’Souza, D.H. Effect of chitosan on the infectivity of murine norovirus, feline calicivirus, and bacteriophage MS2. J. Food Protect. 2009, 72, 2623–2628.
[96]
Mazumder, S.; Ghosal, P.K.; Pujol, C.A.; Carlucci, M.J.; Damonte, E.B.; Ray, B. Isolation, chemical investigation and antiviral activity of polysaccharides from Gracilaria corticata (Gracilariaceae, Rhodophyta). Int. J. Biol. Macromol. 2002, 31, 87–95, doi:10.1016/S0141-8130(02)00070-3.
[97]
Carlucci, M.J.; Pujol, C.A.; Ciancia, M.; Noseda, M.D.; Matulewicz, M.C.; Damonte, E.B.; Cerezo, A.S. Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: Correlation between structure and biological activity. Int. J. Biol. Macromol. 1997, 20, 97–105, doi:10.1016/S0141-8130(96)01145-2.
[98]
Carlucci, M.J.; Scolaro, L.A.; Damonte, E.B. Inhibitory action of natural carrageenans on herpes simplex virus infection of mouse astrocytes. Chemotheraphy 1999, 45, 429–436, doi:10.1159/000007236.
[99]
Trinchero, J.; Ponce, N.M.; Córdoba, O.L.; Flores, M.L.; Pampuro, S.; Stortz, C.A.; Salomón, H.; Turk, G. Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis. Phytother. Res. 2009, 23, 707–712, doi:10.1002/ptr.2723.
Majczak, G.A.H.; Richartz, R.R.T.B.; Duarte, M.E.R.; Noseda, M.D. Antiherpetic Activity of Heterofucans Isolated from Sargassum stenophyllum (Fucales, Phaeophyta). In Proceedings of the 17th International Seaweed Symposium, Cape Town, South Africa, 28 January–2 February 2001; Chapman, A.R.O., Anderson, R.J., Vreeland, V.J., Davison, I.R., Eds.; Oxford University Press: Oxford, UK, 2003; pp. 169–174.
[102]
Ponce, N.M.A.; Pujol, C.A.; Damonte, E.B.; Flores, M.L.; Stortz, C.A. Fucoidans from the brown seaweed Adenocystis utricularis: Extraction methods, antiviral activity and structural studies. Carbohydr. Res. 2003, 338, 153–165, doi:10.1016/S0008-6215(02)00403-2.
[103]
Baba, M.; Snoeck, R.; Pauwels, R.; de Clercq, E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Chemother. 1988, 32, 1742–1745, doi:10.1128/AAC.32.11.1742.
[104]
Mercer, J.; Schelhaas, M.; Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 2010, 79, 803–833, doi:10.1146/annurev-biochem-060208-104626.
[105]
Talarico, L.B.; Duarte, M.E.R.; Zibetti, R.G.M.; Noseda, M.D.; Damonte, E.B. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection. Planta Med. 2007, 73, 1464–1468, doi:10.1055/s-2007-990241.
[106]
González, M.E.; Alarcón, B.; Carrasco, L. Polysaccharides as antiviral agents: Antiviral activity of carrageenan. Antimicrob. Agents Chemother. 1987, 31, 1388–1393, doi:10.1128/AAC.31.9.1388.
[107]
Turner, E.V.; Sonnenfeld, G. Interferon induction by the immunomodulating polyanion Lambda carrageenan. Infect. Immun. 1979, 25, 467–469.
[108]
Zhou, G.; Sun, Y.P.; Xin, H.; Zhang, Y.; Li, Z.; Xu, Z. In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol. Res. 2004, 50, 47–53, doi:10.1016/j.phrs.2003.12.002.
[109]
Yuan, H.M.; Song, J.M.; Li, X.G.; Li, X.G.; Li, N.; Dai, J.C. Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides. Cancer Lett. 2006, 243, 228–234, doi:10.1016/j.canlet.2005.11.032.
[110]
Kim, J.-K.; Cho, M.L.; Karnjanapratum, S.; Shin, I.-S.; You, S.G. In vitro and in vivo immunomodulatory activity of sulfated polysaccharides from Enteromorpha prolifera. Int. J. Biol. Macromol. 2011, 49, 1051–1058, doi:10.1016/j.ijbiomac.2011.08.032.
[111]
Patel, S. Therapeutic importance of sulfated polysaccharides from seaweeds: Updating the recent findings. 3 Biotech 2012, 2, 171–185, doi:10.1007/s13205-012-0061-9.
[112]
Witvrouw, M.; de Clercq, E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharm. 1997, 29, 497–511, doi:10.1016/S0306-3623(96)00563-0.
[113]
Ghosh, T.; Chattopadhyay, K.; Marschall, M.; Karmakar, P.; Mandal, P.; Ray, B. Focus on antivirally active sulfated polysaccharides: From structure-activity analysis to clinical evaluation. Glycobiology 2009, 19, 2–15.
